record_id string | scenario string | year int64 | setting string | test_method string | medicine_tested string | sample_source string | iso_17025 int64 | who_pq_lab int64 | quality_manual int64 | proficiency_testing int64 | equipment_functional int64 | hplc_available int64 | calibrated_current int64 | maintenance_contract int64 | reagent_available int64 | reference_standard_available int64 | staff_qualified int64 | analyst_trained int64 | staff_count int64 | vacancies int64 | samples_year int64 | turnaround_days int64 | test_completed int64 | result_accurate int64 | sf_detected int64 | api_failure int64 | reported_to_nmra int64 | budget_adequate int64 | donor_funded int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAT-00100 | national_qc_laboratory | 2,012 | national_qc_lab | disintegration | antihypertensive | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 11 | 2 | 527 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00101 | national_qc_laboratory | 2,017 | private_contract_lab | HPLC | antidiabetic | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 5 | 2 | 525 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00102 | national_qc_laboratory | 2,014 | university_lab | HPLC | antihypertensive | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 9 | 3 | 504 | 32 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00103 | national_qc_laboratory | 2,013 | national_qc_lab | dissolution | antidiabetic | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 7 | 3 | 487 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00104 | national_qc_laboratory | 2,016 | university_lab | dissolution | antidiabetic | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 523 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00105 | national_qc_laboratory | 2,019 | national_qc_lab | disintegration | anti_TB | routine | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 1 | 474 | 44 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00106 | national_qc_laboratory | 2,013 | regional_qc_lab | TLC | antimalarial | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 12 | 3 | 528 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00107 | national_qc_laboratory | 2,015 | university_lab | dissolution | ARV | research | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 5 | 471 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00108 | national_qc_laboratory | 2,014 | national_qc_lab | HPLC | antihypertensive | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 12 | 3 | 485 | 38 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00109 | national_qc_laboratory | 2,016 | national_qc_lab | HPLC | antidiabetic | post_market | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 8 | 2 | 520 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00110 | national_qc_laboratory | 2,021 | national_qc_lab | dissolution | analgesic | post_market | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 3 | 2 | 505 | 19 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00111 | national_qc_laboratory | 2,017 | regional_qc_lab | Karl_Fischer | anti_TB | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 15 | 2 | 478 | 26 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00112 | national_qc_laboratory | 2,023 | national_qc_lab | HPLC | antibiotic | complaint | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 11 | 2 | 463 | 18 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
NAT-00113 | national_qc_laboratory | 2,016 | regional_qc_lab | HPLC | antimalarial | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 4 | 3 | 504 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00114 | national_qc_laboratory | 2,020 | regional_qc_lab | TLC | antihypertensive | complaint | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 4 | 516 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00115 | national_qc_laboratory | 2,016 | national_qc_lab | disintegration | antimalarial | research | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 2 | 552 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00116 | national_qc_laboratory | 2,017 | private_contract_lab | HPLC | other | research | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 528 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00117 | national_qc_laboratory | 2,020 | university_lab | HPLC | antidiabetic | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6 | 0 | 459 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00118 | national_qc_laboratory | 2,013 | national_qc_lab | Karl_Fischer | antimalarial | port_entry | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 1 | 553 | 22 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00119 | national_qc_laboratory | 2,011 | national_qc_lab | dissolution | antihypertensive | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 497 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00120 | national_qc_laboratory | 2,014 | university_lab | HPLC | analgesic | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 9 | 3 | 509 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00121 | national_qc_laboratory | 2,022 | university_lab | TLC | antibiotic | manufacturer | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 2 | 493 | 41 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00122 | national_qc_laboratory | 2,020 | university_lab | HPLC | ARV | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 11 | 2 | 514 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00123 | national_qc_laboratory | 2,022 | university_lab | TLC | antimalarial | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 9 | 4 | 498 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00124 | national_qc_laboratory | 2,014 | university_lab | dissolution | analgesic | routine | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 3 | 510 | 45 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00125 | national_qc_laboratory | 2,023 | regional_qc_lab | HPLC | antibiotic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 455 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00126 | national_qc_laboratory | 2,012 | university_lab | HPLC | antihypertensive | post_market | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 5 | 1 | 529 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00127 | national_qc_laboratory | 2,018 | regional_qc_lab | HPLC | antidiabetic | post_market | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 16 | 0 | 494 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00128 | national_qc_laboratory | 2,019 | national_qc_lab | visual_inspection | antibiotic | manufacturer | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 503 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00129 | national_qc_laboratory | 2,014 | regional_qc_lab | HPLC | antihypertensive | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 6 | 2 | 501 | 30 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00130 | national_qc_laboratory | 2,021 | private_contract_lab | TLC | antidiabetic | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 1 | 469 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00131 | national_qc_laboratory | 2,013 | private_contract_lab | HPLC | analgesic | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 1 | 506 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00132 | national_qc_laboratory | 2,010 | regional_qc_lab | HPLC | antimalarial | routine | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 3 | 524 | 38 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
NAT-00133 | national_qc_laboratory | 2,018 | university_lab | HPLC | antidiabetic | manufacturer | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 7 | 3 | 500 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00134 | national_qc_laboratory | 2,017 | university_lab | TLC | antimalarial | research | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 8 | 2 | 518 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00135 | national_qc_laboratory | 2,012 | national_qc_lab | dissolution | antimalarial | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 1 | 491 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00136 | national_qc_laboratory | 2,014 | private_contract_lab | HPLC | anti_TB | post_market | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 2 | 530 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00137 | national_qc_laboratory | 2,011 | university_lab | HPLC | antihypertensive | routine | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 527 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00138 | national_qc_laboratory | 2,020 | university_lab | dissolution | antimalarial | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 1 | 489 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00139 | national_qc_laboratory | 2,017 | national_qc_lab | HPLC | other | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 7 | 3 | 530 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00140 | national_qc_laboratory | 2,020 | national_qc_lab | HPLC | antibiotic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 14 | 1 | 486 | 33 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00141 | national_qc_laboratory | 2,014 | university_lab | visual_inspection | analgesic | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 10 | 0 | 509 | 57 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00142 | national_qc_laboratory | 2,010 | university_lab | disintegration | antidiabetic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 11 | 0 | 497 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00143 | national_qc_laboratory | 2,020 | national_qc_lab | microbial_limit | other | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 7 | 0 | 498 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00144 | national_qc_laboratory | 2,019 | university_lab | UV_spectroscopy | analgesic | manufacturer | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 10 | 1 | 474 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00145 | national_qc_laboratory | 2,015 | national_qc_lab | UV_spectroscopy | antibiotic | routine | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 8 | 1 | 513 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00146 | national_qc_laboratory | 2,016 | national_qc_lab | HPLC | antihypertensive | routine | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 9 | 4 | 512 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00147 | national_qc_laboratory | 2,015 | regional_qc_lab | UV_spectroscopy | antihypertensive | manufacturer | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 10 | 2 | 506 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00148 | national_qc_laboratory | 2,020 | regional_qc_lab | HPLC | anti_TB | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 508 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00149 | national_qc_laboratory | 2,017 | university_lab | HPLC | vaccine | manufacturer | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 9 | 2 | 445 | 24 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
NAT-00150 | national_qc_laboratory | 2,013 | regional_qc_lab | HPLC | antimalarial | complaint | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 501 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00151 | national_qc_laboratory | 2,021 | national_qc_lab | HPLC | antimalarial | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 6 | 1 | 539 | 58 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00152 | national_qc_laboratory | 2,015 | university_lab | disintegration | other | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 15 | 0 | 507 | 8 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00153 | national_qc_laboratory | 2,022 | national_qc_lab | disintegration | anti_TB | manufacturer | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 1 | 530 | 35 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00154 | national_qc_laboratory | 2,020 | university_lab | dissolution | other | port_entry | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 10 | 1 | 489 | 29 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00155 | national_qc_laboratory | 2,013 | national_qc_lab | disintegration | analgesic | routine | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11 | 1 | 476 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00156 | national_qc_laboratory | 2,017 | national_qc_lab | microbial_limit | other | port_entry | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 494 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00157 | national_qc_laboratory | 2,017 | university_lab | HPLC | antimalarial | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 10 | 0 | 489 | 31 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
NAT-00158 | national_qc_laboratory | 2,016 | regional_qc_lab | disintegration | anti_TB | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 9 | 3 | 477 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00159 | national_qc_laboratory | 2,015 | national_qc_lab | HPLC | other | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 1 | 529 | 39 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00160 | national_qc_laboratory | 2,020 | national_qc_lab | visual_inspection | anti_TB | routine | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 8 | 3 | 515 | 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00161 | national_qc_laboratory | 2,013 | national_qc_lab | TLC | antibiotic | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 | 3 | 481 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00162 | national_qc_laboratory | 2,021 | university_lab | HPLC | other | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 2 | 522 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00163 | national_qc_laboratory | 2,016 | university_lab | dissolution | antibiotic | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 | 1 | 547 | 37 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
NAT-00164 | national_qc_laboratory | 2,016 | national_qc_lab | visual_inspection | other | research | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 3 | 1 | 508 | 50 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00165 | national_qc_laboratory | 2,019 | national_qc_lab | disintegration | ARV | port_entry | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 12 | 2 | 506 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00166 | national_qc_laboratory | 2,020 | university_lab | HPLC | antibiotic | port_entry | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 7 | 3 | 527 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00167 | national_qc_laboratory | 2,021 | private_contract_lab | disintegration | antimalarial | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 3 | 514 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00168 | national_qc_laboratory | 2,022 | university_lab | HPLC | ARV | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 5 | 1 | 504 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00169 | national_qc_laboratory | 2,014 | university_lab | HPLC | ARV | post_market | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 524 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00170 | national_qc_laboratory | 2,023 | national_qc_lab | disintegration | anti_TB | port_entry | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 9 | 1 | 456 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00171 | national_qc_laboratory | 2,011 | university_lab | TLC | analgesic | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 14 | 4 | 533 | 43 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00172 | national_qc_laboratory | 2,024 | national_qc_lab | dissolution | anti_TB | routine | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 0 | 514 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00173 | national_qc_laboratory | 2,017 | private_contract_lab | HPLC | anti_TB | research | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 12 | 2 | 512 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00174 | national_qc_laboratory | 2,016 | university_lab | UV_spectroscopy | antidiabetic | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 7 | 2 | 480 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00175 | national_qc_laboratory | 2,014 | national_qc_lab | TLC | analgesic | complaint | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 1 | 507 | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00176 | national_qc_laboratory | 2,022 | private_contract_lab | dissolution | antibiotic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 1 | 498 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00177 | national_qc_laboratory | 2,024 | national_qc_lab | disintegration | antimalarial | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 8 | 2 | 493 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00178 | national_qc_laboratory | 2,022 | national_qc_lab | HPLC | antibiotic | routine | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 4 | 2 | 486 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00179 | national_qc_laboratory | 2,024 | private_contract_lab | HPLC | anti_TB | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 13 | 1 | 455 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00180 | national_qc_laboratory | 2,021 | regional_qc_lab | HPLC | antihypertensive | post_market | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 537 | 55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00181 | national_qc_laboratory | 2,022 | private_contract_lab | disintegration | ARV | port_entry | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 10 | 1 | 450 | 37 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00182 | national_qc_laboratory | 2,011 | private_contract_lab | HPLC | antibiotic | routine | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 8 | 5 | 491 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00183 | national_qc_laboratory | 2,017 | regional_qc_lab | dissolution | antibiotic | research | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 6 | 2 | 496 | 33 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00184 | national_qc_laboratory | 2,020 | regional_qc_lab | dissolution | other | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 13 | 3 | 492 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00185 | national_qc_laboratory | 2,013 | regional_qc_lab | UV_spectroscopy | antimalarial | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 526 | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00186 | national_qc_laboratory | 2,021 | national_qc_lab | dissolution | ARV | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 9 | 0 | 521 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00187 | national_qc_laboratory | 2,016 | regional_qc_lab | HPLC | ARV | port_entry | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 5 | 1 | 506 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00188 | national_qc_laboratory | 2,021 | national_qc_lab | TLC | antimalarial | port_entry | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 513 | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00189 | national_qc_laboratory | 2,024 | national_qc_lab | UV_spectroscopy | analgesic | complaint | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 10 | 1 | 529 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00190 | national_qc_laboratory | 2,024 | regional_qc_lab | dissolution | antihypertensive | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 9 | 3 | 486 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00191 | national_qc_laboratory | 2,020 | regional_qc_lab | HPLC | antidiabetic | post_market | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 1 | 479 | 57 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00192 | national_qc_laboratory | 2,024 | university_lab | HPLC | ARV | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | 3 | 500 | 68 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00193 | national_qc_laboratory | 2,021 | university_lab | UV_spectroscopy | anti_TB | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 495 | 59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00194 | national_qc_laboratory | 2,021 | private_contract_lab | visual_inspection | antimalarial | routine | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 3 | 477 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00195 | national_qc_laboratory | 2,013 | national_qc_lab | microbial_limit | ARV | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 4 | 3 | 539 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00196 | national_qc_laboratory | 2,021 | national_qc_lab | Karl_Fischer | antimalarial | research | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 17 | 1 | 499 | 29 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00197 | national_qc_laboratory | 2,021 | university_lab | TLC | other | port_entry | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 2 | 470 | 51 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
NAT-00198 | national_qc_laboratory | 2,017 | national_qc_lab | visual_inspection | antihypertensive | routine | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 459 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00199 | national_qc_laboratory | 2,020 | university_lab | disintegration | ARV | routine | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 9 | 2 | 497 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.